Radial Access Cuts Vascular Complications in Angiography

Share this content:
Radial Access Cuts Vascular Complications in Angiography
Radial Access Cuts Vascular Complications in Angiography

THURSDAY, April 23, 2015 (HealthDay News) -- Women undergoing coronary angiography and percutaneous coronary intervention (PCI) have a higher rate of vascular complications than men, which are significantly reduced with radial access, according to a study published in the April 20 issue of JACC: Cardiovascular Interventions.

Shaheen Pandie, M.B., Ch.B., from McMaster University and Population Health Research Institute in Hamilton, Canada, and colleagues determined the efficacy and safety of radial versus femoral access among women undergoing coronary angiography/intervention. Outcomes were compared for 1,861 women and 5,160 men randomized to radial versus femoral access.

The researchers found that the risk of major vascular complications was higher for women than men (4.7 versus 1.7 percent; P < 0.0001). In women and men, major vascular complications were significantly reduced with radial access (hazard ratios, 0.5 and 0.27, respectively). In women and men, crossover rates were higher with radial versus femoral access (hazard ratios, 5.88 and 3.32, respectively). Similar PCI success rates were observed, regardless of access site, with no differences in PCI complications. Female sex was an independent predictor of major vascular complications in multivariable analyses (hazard ratio, 2.39). Findings were consistent for women and men, with no difference for the primary composite end point (death, myocardial infarction, stroke, and non-coronary artery bypass graft bleeding).

"Women undergoing coronary angiography and PCI have a higher risk of vascular access site complications compared with men, and radial access is an effective method to reduce these complications," the authors write.

Two authors disclosed financial ties to the pharmaceutical and medical device industries.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »